Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69 USD | -4.34% |
|
+0.63% | -8.33% |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.78 for the current period. Therefore, the company is undervalued.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.33% | 8.43B | - | ||
-5.23% | 1.38B | D | ||
-6.68% | 1.2B | - | ||
-26.51% | 770M | - | - | |
-.--% | 617M | - | - | |
+2.82% | 466M | - | ||
+2.04% | 433M | - | - | |
-31.93% | 301M | - | - | |
-62.43% | 269M | - | ||
-1.17% | 216M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- 0L3C Stock
- Ratings Henry Schein, Inc.